Development of Rheumatoid Arthritis in Cavitary Mycobacterium avium Pulmonary Disease: A Case Report of Successful Treatment with CTLA4-Ig (Abatacept).
Hiromu TanakaTakanori AsakuraJun KikuchiMakoto IshiiHo NamkoongYuko KanekoKoichi FukunagaNaoki HasegawaPublished in: Infection and drug resistance (2022)
Physicians should be mindful of the etiologies of bronchiectasis, including RA, even in patients with a long-term history of treatment for bronchiectasis and NTM-PD. When NTM-PD is well controlled, even with remaining cavitary lesions, abatacept may be an option for patients with RA based on a comprehensive assessment of disease progression using NTM sputum smear/culture, computed tomography findings, and treatment response.
Keyphrases
- rheumatoid arthritis
- cystic fibrosis
- disease activity
- computed tomography
- mycobacterium tuberculosis
- pulmonary tuberculosis
- ankylosing spondylitis
- interstitial lung disease
- primary care
- pulmonary hypertension
- rheumatoid arthritis patients
- positron emission tomography
- magnetic resonance imaging
- magnetic resonance
- combination therapy
- image quality
- systemic sclerosis